REXULTI
Otsuka Pharmaceutical Co., Ltd.
Application Filed: 2017-12-14
Trademark Application Details
REGISTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79229625 |
| Registration Number | 5688217 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Kazuyo Morita |
| Attorney Docket Number | 57182.0363 |
| Law Office Assigned | L40 |
| Employee Name | PARK, JENNY K |
Timeline
| 2017-12-14 | Application Filed |
| 2018-12-18 | Published for Opposition |
| 2019-03-05 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-03-05 | Status: Live/Registered |
| 2019-03-05 | Trademark Registered |
| 2019-07-12 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Otsuka Pharmaceutical Co., Ltd. |
| Address | 2-9 Kanda-Tsukasamachi, Chiyoda-ku Tokyo JP 101-8535 |
| Legal Entity Type | Corporation |
| Legal Entity State | JP |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0101 | Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseases, dementia, Alzheimer's disorder and disease, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disorder and disease, insomnia, Parkinson's disorder and disease, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, progressive supranuclear palsy (PSP), restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; Injection devices for medical purposes; syringes and needles for injections and medical purposes; Apparatus and instruments for diagnostic purposes, namely, integrated medical systems comprising medical diagnostic imaging apparatus and software sold as a unit therewith for managing, measuring, monitoring, assessing, controlling, collecting, storing, and examining patient and client data and information captured by the medical system in web-based physical, psychological and neurological examinations conducted at a distance and at a clinic; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2018-04-05 | 1 REPR M: |
| LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2018-04-09 | 2 LIMI I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-04-10 | 3 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-04-10 | 4 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2018-04-14 | 5 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2018-04-17 | 6 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2018-04-18 | 7 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2018-04-23 | 8 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2018-04-23 | 9 RFCS P: |
| REFUSAL PROCESSED BY IB | 2018-05-12 | 10 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-10-08 | 11 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2018-10-17 | 12 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-10-23 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-10-23 | 14 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-11-08 | 15 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-11-28 | 16 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2018-11-28 | 17 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2018-11-28 | 18 OPNS P: |
| NOTIFICATION PROCESSED BY IB | 2018-12-15 | 19 GPNX P: |
| PUBLISHED FOR OPPOSITION | 2018-12-18 | 20 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-12-18 | 21 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2019-03-05 | 22 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2019-06-05 | 23 FICR P: |
| FINAL DISPOSITION PROCESSED | 2019-06-26 | 24 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2019-06-26 | 25 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2019-07-12 | 26 FINO P: |
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2024-03-05 | 27 REM3 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 REXULTI 79229625 5688217 Live/Registered |
Otsuka Pharmaceutical Co., Ltd. 2017-12-14 |
 REXULTI 79114561 4287396 Live/Registered |
Otsuka Pharmaceutical Co., Ltd. 2012-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 